Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Shares, par value (euro)0.12 per share
-
Shares outstanding
-
22,421,536
-
Total 13F shares
-
11,129,364
-
Share change
-
-2,210,702
-
Total reported value
-
$32,809,500
-
Put/Call ratio
-
76%
-
Price per share
-
$2.94
-
Number of holders
-
78
-
Value change
-
-$7,039,565
-
Number of buys
-
33
-
Number of sells
-
45
Institutional Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) as of Q3 2024
As of 30 Sep 2024 CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) had 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,129,364 shares of stock of the company.
Largest 10 holders included MILLENNIUM MANAGEMENT LLC, Bill & Melinda Gates Foundation, BlackRock, Inc., CITADEL ADVISORS LLC, Point72 Asset Management, L.P., Alyeska Investment Group, L.P., GOLDMAN SACHS GROUP INC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 78 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.